Biological E enters into pact to buy Dynavax#39;s adjuvant for use in COVID-19 subunit vaccine

Biological E enters into pact to buy Dynavax#39;s adjuvant for use in COVID-19 subunit vaccine The agreement includes doses for delivery in 2021, which were manufactured under the previously announced funding agreement between the Coalition for Epidemic Preparedness Innovations and Dynavax. India entered into an advance purchase deal with BE to buy 30 crore doses.

No comments:

Post a Comment